Winston-Salem’s Plakous Therapeutics lands $1.7M fast-track SBIR grant
Plakous is developing human placenta-derived regenerative therapies, initially focused on Protego-PD, a platform product to treat a devastating and costly disease of premature babies called necrotizing enterocolitis (NEC).
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed